Upgrade

Biomotion Sciences Warrant

SLXNW

Last
$0.01
Day
-1.7%
1y
-84.5%
5y
-93.5%
52w
-96.1%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
0.01
EMA 50
0.01
EMA 200
0.03
20d high
-57.9%
5y high
-96.1%
5y range
1th
Website · 13 employees · Israel

Positions held

Your positions

SLXNW isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-6
Hold
avoid
Signal
Sell
Target
$0.01
Stop
$0.00
Stop distance
100.0%
Target vs last
+69.5%

Fundamentals

Market cap—Enterprise value—Trailing P/E—Forward P/E—
PEG—Price / book0.74Beta-0.30Dividend yield—
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE—ROA—Debt / equity32.05
Current ratio0.94Free cash flow—Analyst recommendationnoneMean target—
52w high$0.0152w low$0.01

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.0M$0.0M$0.0M$0.0M—
Op margin——————
Net income-$3.6M-$2.7M-$4.4M-$3.3M-$2.5M—
Gross margin——————
Gross profit——————
Operating income-$3.7M-$2.7M-$4.4M-$3.3M-$2.3M—

Yearly (6y)

2025202420232022
Revenue$0.0M$0.0M$0.0M$0.0M
Op margin————
Net income-$11.9M-$16.4M-$4.9M-$3.2M
Gross margin————
Gross profit————
Operating income-$11.6M-$12.6M-$4.7M-$3.9M
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

No headlines.

SLXNW · daily-22.4% over 11 sessions
Close EMA21 EMA50 EMA200
0.000.010.010.010.012026-092026-092026-092026-092026-092026-092026-092026-102026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$4M-$3M-$2M-$1M$0M0%5%10%2025-Q22025-Q32025-Q42026-Q12026-Q2